Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

Journal of Hepatology · 2012 · 2.9K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Liver Transplantation in European Patients with the Hepatitis B Surface Antigen

Didier Samuel, R. Müller, Graeme Alexander et al. · New England Journal of Medicine · 1993 · 1.1K citations · Full text

Medicine, Immunology, Infectious Diseases +12

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote et al. · Gastroenterology · 2006 · 882 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2009 · 816 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B

Ching‐Lung Lai, Edward Gane, Yun‐Fan Liaw et al. · New England Journal of Medicine · 2007 · 775 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17